Mc Coy Drugs Private Limited

Produces a variety of pharmaceuticals and chemicals, including anti-malarial, anti-inflammatory, and antibiotics.

2004 | Surat, Gujarat (India) | Active
Last Updated: December 19, 2024

Mc Coy Drugs Profile

Key Indicators

  • Authorised Capital ₹ 5.00 Cr
  • Paid Up Capital ₹ 4.84 Cr
  • Company Age 20 Year, 8 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 4.75 Cr
  • Satisfied Charges ₹ 4.70 Cr
  • Revenue Growth -62.64%
  • Profit Growth -81.73%
  • Ebitda -10.25%
  • Net Worth 0.15%
  • Total Assets -28.72%

About Mc Coy Drugs

Mc Coy Drugs Private Limited (MCDPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 04 June 2004 and has a history of 20 years and eight months. Its registered office is in Surat, Gujarat, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 Cr and a paid-up capital of Rs 4.84 Cr.

The company currently has active open charges totaling ₹4.75 Cr. The company has closed loans amounting to ₹4.70 Cr, as per Ministry of Corporate Affairs (MCA) records.

Rinamkumar Shah, Suken Shah, Mehul Choksi, and One other member serve as directors at the Company.

Company Details

  • Location

    Surat, Gujarat, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

    mccoydrugs.com

  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24230GJ2004PTC098840

  • Company No.

    098840

  • Company Classification

    Private Limited Indian Non-Government Company

  • Incorporation Date

    04 Jun 2004

  • Date of AGM

    30 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Ahmedabad

Industry

Pharma

What products or services does Mc Coy Drugs Private Limited offer?

Mc Coy Drugs Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Nervous System and Antipsychotic API, API (Active Pharmaceutical Ingredients), Antipyretic and Analgesic API, Chemical Intermediates, Acrylic Acid, Pantoprazole Drugs, Pantoprazole Sodium Injection, Caustic Soda, Caustic Soda Flakes.

Who are the key members and board of directors at Mc Coy Drugs?

Board Members (4)

NameDesignationAppointment DateStatus
Mehul Choksi Country flag representing In Director 10-Feb-2016Current
Rinamkumar Shah Country flag representing In Director 01-Jul-2004Current
Suken Shah Country flag representing In Director 10-Feb-2016Current
Nihar Shah Country flag representing In Director 30-Dec-2022Current

Financial Performance of Mc Coy Drugs.

Mc Coy Drugs Private Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 62.64% decrease. The company also saw a substantial fall in profitability, with a 81.73% decrease in profit. The company's net worth moved up by a moderate rise of 0.15%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-62.64%
Revenue from Operations
-62.61%
Total Assets
-28.72%
Profit or Loss
-81.73%
Net Worth
0.15%
EBITDA
-10.25%

What is the Ownership and Shareholding Structure of Mc Coy Drugs?

In 2021, Mc Coy Drugs had a promoter holding of 45.66% and a public holding of 54.34%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹4.75 Cr

Satisfied Charges

₹4.70 Cr

Charges Breakdown by Lending Institutions

  • Others : 3.25 Cr
  • Tata Capital Financial Services Limited : 1.50 Cr

Latest Charge Details

DateLenderAmountStatus
27 Jul 2020Others₹2.50 MOpen
18 Jul 2018Tata Capital Financial Services Limited₹1.50 CrOpen
04 Sep 2017Others₹3.00 CrOpen
05 Oct 2009The Cosmos Co-Operative Bank Ltd.₹1.90 CrSatisfied
05 Oct 2009The Cosmos Co-Operative Bank Limited₹2.80 CrSatisfied

How Many Employees Work at Mc Coy Drugs?

Unlock and access historical data on people associated with Mc Coy Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Mc Coy Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mc Coy Drugs's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Mc Coy Drugs

Recent activity within the organization

  • Annual General Meeting

    Mc Coy Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Mc Coy Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad.

    31 Mar 2024

  • Director Appointment

    Nihar Shah was appointed as a Director was appointed as a Director on 30 Dec 2022 & has been associated with this company since 2 years 1 month .

    30 Dec 2022

  • Charges

    A charge registered on 05 Oct 2009 via Charge ID 10184112 with The Cosmos Co-Operative Bank Ltd. was fully satisfied on 14 Jul 2022.

    14 Jul 2022

  • Charges

    A charge registered on 05 Oct 2009 via Charge ID 10184116 with The Cosmos Co-Operative Bank Limited was fully satisfied on 14 Jul 2022.

    14 Jul 2022

  • Charges

    A charge with Others amounted to Rs. 0.25 Cr with Charge ID 100356026 was registered on 27 Jul 2020.

    27 Jul 2020

Frequently asked questions

  • Mc Coy Drugs Private Limited was incorporated on 04 Jun 2004.

  • The authorized share capital of Mc Coy Drugs Private Limited is ₹ 5.00 Cr and paid-up capital is ₹ 4.84 Cr.

  • Currently 4 directors are associated with Mc Coy Drugs Private Limited.

    • Rinamkumar Nalinkumar Shah
    • Suken Dineshchandra Shah
    • Mehul Satish Choksi
    • Nihar Shah
  • As per Ministry of Corporate Affairs (Mca), the registered address of Mc Coy Drugs Private Limited is Plot No.146-147 Sez Sachin, India, Surat, Gujarat, 394320.

  • The corporate identification number (CIN) of Mc Coy Drugs Private Limited is U24230GJ2004PTC098840 and the company number is 098840 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Mc Coy Drugs Private Limited is https://www.mccoydrugs.com

  • According to the financial reports for the fiscal year 2021, the revenue trend for Mc Coy Drugs Private Limited has fallen by -62.64%.

  • The financial reports for the fiscal year 2021 indicates that The net worth of Mc Coy Drugs Private Limited has experienced an upsurge of 0.15%.

  • As per the financial statements for fiscal Year 2021, The total open charges for Mc Coy Drugs Private Limited amount to ₹ 4.75 Cr.

  • The most recent Balance Sheet for Mc Coy Drugs Private Limited was filed with the ROC on 31 Mar 2024.

People also Viewed

Similar Companies Based on Drug Formulation & Development